Greatest Advancements in Oculoplastics- Dr. Ana Carolina Victoria

Dr. Ana Carolina Victoria shares with us what she thinks is one of the greatest advancements🔬 in #oculoplastics in recent years. For her, it is the introduction and success of targeted biologic therapies for thyroid eye disease (TED). Specifically, the development of #Teprotumumab, a monoclonal antibody, has been a game-changer in the treatment of TED. This drug targets the insulin-like growth factor-1 receptor (IGF-1R) and has shown remarkable efficacy in reducing proptosis (eye bulging), inflammation, and improving the overall quality of life for patients with active TED. The ability to treat💊 the disease medically, rather than relying solely on surgical interventions, represents a significant advancement in oculoplastics, providing a more effective and less invasive treatment option for patients suffering from this challenging condition. #ted #thyroideyedisease #drmiamiface Dr. Victoria Financial Disclosures: Amgen